Ginkgo Bioworks

Founded: 2008 · Boston, United States · 501-1000 employees · Public

About Ginkgo Bioworks

Ginkgo Bioworks is a biotechnology company that builds a leading platform for cell programming and biosecurity, providing automated organism engineering services. They leverage AI and robotics in their autonomous labs to accelerate bioengineering across biopharma, agriculture, and industrial biotech industries, enabling customers to program cells as easily as computers.

Company Details

Website
https://www.ginkgobioworks.com
Funding
IPO
Total Raised
$796M
Stock Ticker
DNA
LinkedIn
https://www.linkedin.com/company/ginkgo-bioworks/
GitHub
https://github.com/ginkgobioworks

Specializations

  • Biotechnology
  • Synthetic Biology
  • Cell Programming
  • Bioengineering
  • AI/ML

Products & Solutions (5)

ProductCategorySub-CategoryDescription
AI Models and Fine-Tuning Solutionsresearch-developmentDrug Discovery AIAI models and fine-tuning solutions for biological research, including protein language and promoter activity models.
Concentric by Ginkgoresearch-developmentResearch DiscoveryBuilding global infrastructure for pathogen detection and response to predict, prevent, and react to biological threats.
Ginkgo Automationresearch-developmentLab Management & ELNFlexible, scalable lab automation systems for your evolving science, business, and lab space.
Ginkgo Datapointsresearch-developmentResearch DiscoveryTransforming AI model training in biology with large-scale, automated lab data.
Ginkgo R&D Solutionsresearch-developmentResearch DiscoveryAccelerate biotech R&D with customizable solutions for protein engineering, nucleic acid design, and cell-free systems.

Notable Customers

  • Novo Nordisk
  • Pfizer
  • Bayer
  • Biogen
  • Corteva
  • Ajinomoto
  • Novartis
  • Kerry